Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$0.60 USD
+0.05 (8.20%)
Updated Oct 16, 2024 03:59 PM ET
After-Market: $0.60 0.00 (0.81%) 6:42 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Predictive Oncology Inc. (POAI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.00 | $3.00 | $3.00 | 445.45% |
Price Target
Only one analyst offered a short-term price target of $3.00 for Predictive Oncology Inc. This represents an increase of 445.45% from the last closing price of $0.55.
Analyst Price Targets (1 )
Broker Rating
Only one brokerage firm provided a Strong Buy-equivalent recommendation for Predictive Oncology Inc. This translates to an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell). ABR is the calculated average of actual recommendations (Buy, Hold, Sell etc.) made by brokerage firms.
The current ABR compares to an ABR of 1.00 a month ago based on just one Strong Buy recommendation.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | NA |
Buy | 0 | 0 | 0 | 0 | NA |
Hold | 0 | 0 | 0 | 0 | NA |
Sell | 0 | 0 | 0 | 0 | NA |
Strong Sell | 0 | 0 | 0 | 0 | NA |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/19/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 1 |
Average Target Price | $3.00 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 74 of 252 |
Current Quarter EPS Est: | -0.32 |
POAI FAQs
Predictive Oncology Inc. (POAI) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 1 brokerage firms.
The average price target for Predictive Oncology Inc. (POAI) is $3.00. The current on short-term price targets is based on 1 reports.
The forecasts for Predictive Oncology Inc. (POAI) range from a low of $3 to a high of $3. The average price target represents a increase of $445.45 from the last closing price of $.55.
The current UPSIDE for Predictive Oncology Inc. (POAI) is 445.45%
Only one analyst offered a short-term price target of $3.00 for Predictive Oncology Inc. This represents an increase of 445.45% from the last closing price of $0.55.